Showing results (381-390 of 420) with videos related to

Sort By:
Pageof 42
Cell Reports|June 20, 2020
Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon SecretionKatrina Viloria, Daniela Nasteska, Linford J B Briant, et al.
Journal of Medicinal Chemistry|November 21, 2024
Covalent Inhibitors of KEAP1 with Exquisite SelectivityImre Fejes, Piroska Markacz, Janos Tatai, et al.
Diabetologia|January 12, 2023
Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expressionKatia K Mattis, Nicole A J Krentz, Christoph Metzendorf, et al.
The Journal of Infectious Diseases|May 22, 2025
Seroprevalence of Dengue, Zika, and Chikungunya Viruses in Humans and Co-located Macaques in Thailand and CambodiaNanthanida Mongkol, Sophana Chea, Somnang Man, et al.
The Journal of Clinical Investigation|September 30, 2025
Altered immune and metabolic molecular pathways drive islet cell dysfunction in human type 1 diabetesTheodore Dos Santos, Xiao-Qing Dai, Robert C Jones, et al.
Lancet (London, England)|March 3, 2023
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trialTimothy J Craig, Avner Reshef, H Henry Li, et al.
Cell Metabolism|February 2, 2022
Heterogenous impairment of α cell function in type 2 diabetes is linked to cell maturation stateXiao-Qing Dai, Joan Camunas-Soler, Linford J B Briant, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2026
Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema AttacksTimothy Craig, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
American Journal of Human Genetics|January 31, 2017
Decreased STARD10 Expression Is Associated with Defective Insulin Secretion in Humans and MiceGaelle R Carrat, Ming Hu, Marie-Sophie Nguyen-Tu, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trialEmel Aygören-Pürsün, Marcin Stobiecki, Anna Valerieva, et al.
Pageof 42